Artificial Intelligence shows promise in detecting breast cancer
A recent study involving Google Health’s DeepMind has shown the potential impact Artificial intelligence (AI) could have on medicine and healthcare. Julie Steenhuysen reported for Reuters on the study, originally published in the journal Nature. The study compared human radiologists and AI in analyzing mammogram results, which are key in detecting breast cancer.
The study included U.S. and U.K. patients, finding “the AI system…[reduced] false positive results by 5.7% in the U.S. … and by 1.2% in the British-based group.” Even more promisingly, the study found the AI reduced false negatives “by 9.4% in the U.S. group and by 2.7% in the British group.”
The study is encouraging, but this sort of AI will not receive approval until much more testing is conducted. AI has already produced superb results in organ donation. Quartz’s Corinne Purtill wrote that AI is largely responsible for the expansion of paired kidney donations, matching anonymous living donors who signed up to donate a kidney with those in need of a transplant.
While hopeful, the development of AI has also raised concerns across applications. Digital privacy is a particularly strong concern for many. DeepMind itself has raised flags primarily for privacy. Engadget’s Georgina Torbet reported that U.K. authorities ruled the National Health Service breached privacy laws by providing DeepMind with “1.6 million patient records” that were used to train AI.
What do you think of this development and the potential future of AI in your healthcare? How should your policymakers in the U.S. and U.K. consider AI in crafting healthcare and tech policy? Reach out and make your voice heard.
Want to embed this Action Button? Use the code below:
<iframe style="width: 100%;" src="https://embed.actionbutton.co/share?widgetId=SPK-QkVDRg%3d%3d&sponsoredContent=false" width="100%" height="450" frameborder="0" scrolling="no"></iframe>